altimmune glp-1 Altimmune's Drug Reduces Heavy Drinking in Alcohol-Use Disorder Trial. Altimmune's pemvidutide achieved a statistically significant reduction in heavy drinking days compared to a placebo in a Phase 2 trial. This peptide Altimmune's GLP-1 drug could help
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



























